Annual EPS
-$3.05
+$1.10+26.51%
December 31, 2023
Summary
- As of February 7, 2025, MNPR annual earnings per share is -$3.05, with the most recent change of +$1.10 (+26.51%) on December 31, 2023.
- During the last 3 years, MNPR annual EPS has fallen by -$0.15 (-5.17%).
- MNPR annual EPS is now -436.12% below its all-time high of -$0.57, reached on December 31, 2016.
Performance
MNPR EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.37
+$0.13+26.00%
September 30, 2024
Summary
- As of February 7, 2025, MNPR quarterly earnings per share is -$0.37, with the most recent change of +$0.13 (+26.00%) on September 30, 2024.
- Over the past year, MNPR quarterly EPS has increased by +$0.13 (+26.00%).
- MNPR quarterly EPS is now -106.82% below its all-time high of -$0.18, reached on March 31, 2017.
Performance
MNPR Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.99
+$0.32+13.85%
September 30, 2024
Summary
- As of February 7, 2025, MNPR TTM earnings per share is -$1.99, with the most recent change of +$0.32 (+13.85%) on September 30, 2024.
- Over the past year, MNPR TTM EPS has increased by +$0.62 (+23.75%).
- MNPR TTM EPS is now -1012.35% below its all-time high of -$0.18, reached on March 31, 2017.
Performance
MNPR TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
MNPR EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.5% | +26.0% | +23.8% |
| 3 y3 years | -5.2% | +63.0% | +44.7% |
| 5 y5 years | -96.9% | +53.8% | +37.8% |
MNPR EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.5% | at high | +67.8% | at high | +52.0% |
| 5 y | 5-year | -35.6% | +26.5% | at high | +67.8% | -7.1% | +52.0% |
| alltime | all time | -436.1% | +61.6% | -106.8% | +94.8% | -1012.4% | +75.9% |
Monopar Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.37(-26.0%) | -$1.99(-13.9%) |
| Jun 2024 | - | -$0.50(0.0%) | -$2.31(-11.5%) |
| Mar 2024 | - | -$0.50(-19.4%) | -$2.61(-14.7%) |
| Dec 2023 | -$3.05(-26.5%) | -$0.62(-10.1%) | -$3.06(-14.8%) |
| Sep 2023 | - | -$0.69(-13.8%) | -$3.59(-6.8%) |
| Jun 2023 | - | -$0.80(-15.8%) | -$3.85(-7.2%) |
| Mar 2023 | - | -$0.95(-17.4%) | -$4.15(0.0%) |
| Dec 2022 | -$4.15(+13.7%) | -$1.15(+21.1%) | -$4.15(+2.5%) |
| Sep 2022 | - | -$0.95(-13.6%) | -$4.05(-1.2%) |
| Jun 2022 | - | -$1.10(+15.8%) | -$4.10(+6.5%) |
| Mar 2022 | - | -$0.95(-9.5%) | -$3.85(+4.1%) |
| Dec 2021 | -$3.65(+25.9%) | -$1.05(+5.0%) | -$3.70(+2.8%) |
| Sep 2021 | - | -$1.00(+17.6%) | -$3.60(+7.5%) |
| Jun 2021 | - | -$0.85(+6.3%) | -$3.35(+4.7%) |
| Mar 2021 | - | -$0.80(-15.8%) | -$3.20(+10.3%) |
| Dec 2020 | -$2.90 | -$0.95(+26.7%) | -$2.90(+15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$0.75(+7.1%) | -$2.52(+18.7%) |
| Jun 2020 | - | -$0.70(+40.0%) | -$2.12(+14.3%) |
| Mar 2020 | - | -$0.50(-12.3%) | -$1.86(-7.9%) |
| Dec 2019 | -$2.25(+45.3%) | -$0.57(+61.4%) | -$2.02(+7.6%) |
| Sep 2019 | - | -$0.35(-18.7%) | -$1.88(+2.5%) |
| Jun 2019 | - | -$0.43(-34.2%) | -$1.83(+4.5%) |
| Mar 2019 | - | -$0.66(+54.6%) | -$1.75(+15.9%) |
| Dec 2018 | -$1.55(-80.5%) | -$0.43(+39.1%) | -$1.51(+5.9%) |
| Sep 2018 | - | -$0.31(-13.8%) | -$1.43(-82.7%) |
| Jun 2018 | - | -$0.36(-15.2%) | -$8.26(+0.9%) |
| Mar 2018 | - | -$0.42(+22.8%) | -$8.18(+3.0%) |
| Dec 2017 | -$7.94(+1296.2%) | -$0.34(-95.2%) | -$7.94(+4.5%) |
| Sep 2017 | - | -$7.14(+2415.2%) | -$7.60(+1542.7%) |
| Jun 2017 | - | -$0.28(+58.6%) | -$0.46(+158.6%) |
| Mar 2017 | - | -$0.18 | -$0.18 |
| Dec 2016 | -$0.57 | - | - |
FAQ
- What is Monopar Therapeutics annual earnings per share?
- What is the all time high annual EPS for Monopar Therapeutics?
- What is Monopar Therapeutics annual EPS year-on-year change?
- What is Monopar Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly EPS year-on-year change?
- What is Monopar Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Monopar Therapeutics?
- What is Monopar Therapeutics TTM EPS year-on-year change?
What is Monopar Therapeutics annual earnings per share?
The current annual EPS of MNPR is -$3.05
What is the all time high annual EPS for Monopar Therapeutics?
Monopar Therapeutics all-time high annual earnings per share is -$0.57
What is Monopar Therapeutics annual EPS year-on-year change?
Over the past year, MNPR annual earnings per share has changed by +$1.10 (+26.51%)
What is Monopar Therapeutics quarterly earnings per share?
The current quarterly EPS of MNPR is -$0.37
What is the all time high quarterly EPS for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly earnings per share is -$0.18
What is Monopar Therapeutics quarterly EPS year-on-year change?
Over the past year, MNPR quarterly earnings per share has changed by +$0.13 (+26.00%)
What is Monopar Therapeutics TTM earnings per share?
The current TTM EPS of MNPR is -$1.99
What is the all time high TTM EPS for Monopar Therapeutics?
Monopar Therapeutics all-time high TTM earnings per share is -$0.18
What is Monopar Therapeutics TTM EPS year-on-year change?
Over the past year, MNPR TTM earnings per share has changed by +$0.62 (+23.75%)